ExpressionEdits
Haverhill
About ExpressionEdits
ExpressionEdits operates in the biotechnology industry, focusing on the redesign of synthetic DNA instructions. The company utilizes an AI-driven approach to redefine the status quo of protein expression. It is involved in building biology similar to nature. The team at ExpressionEdits includes scientists and engineers who are dedicated to developing new technologies. Proteins, a foundational pillar in healthcare and behind every major advancement in biotech and synthetic biology, are at the core of their work.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.0M
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: expressionedits.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/expressionedits-7876 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.